search
Back to results

Surgery or Noninvasive Therapy for Varicose Veins (Magna)

Primary Purpose

Varicose Vein

Status
Unknown status
Phase
Phase 3
Locations
Netherlands
Study Type
Interventional
Intervention
crossectomy and short stripping
ultrasound guided sclerotherapy with foam
endovenous laser therapy
Sponsored by
Erasmus Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Varicose Vein focused on measuring endovenous laser therapy, sclerotherapy, crossectomy and stripping, surgery, treatment, varicose veins

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • primary insufficient GSV confirmed by US: reflux>0.5 sec and diameter>0.5cm.
  • non-treated insufficient GSV
  • >18 years
  • informed consent

Exclusion Criteria:

  • acute thrombosis or phlebitis
  • absence of deep venous system
  • vascular syndromes
  • use of anticoagulants
  • contraindications surgery

Sites / Locations

  • Erasmus MC dermatologyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

1

2

3

Arm Description

Surgery: crossectomy plus short stripping

ultrasound guided sclerotherapy with foam (3% polidocanol)

Endovenous laser therapy (940 nm, about 70 J/cm)

Outcomes

Primary Outcome Measures

anatomical success rate (absence or obliteration of GSV on US examination)

Secondary Outcome Measures

treatment related adverse events and complications
patient reported outcomes (HRQOL and treatment satisfaction)
cost effectiveness analysis

Full Information

First Posted
September 13, 2007
Last Updated
November 15, 2010
Sponsor
Erasmus Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00529672
Brief Title
Surgery or Noninvasive Therapy for Varicose Veins
Acronym
Magna
Official Title
Randomized Single Center Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerotherapy With Foam and Endovenous Laser Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
November 2010
Overall Recruitment Status
Unknown status
Study Start Date
May 2007 (undefined)
Primary Completion Date
May 2011 (Anticipated)
Study Completion Date
May 2011 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Erasmus Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
For more than 100 years, surgery has been the standard of care of varicose veins of the legs. The down side of surgery is that it requires anesthesia, leaves scars, and has a relatively high recurrence rate in the long term (up to 40%). In the last decade, several new techniques have become available but they have not yet been compared to surgery. This trail will evaluate the effectiveness, patients' perspective and cost effectiveness of surgery and non-invasive techniques such as ultrasound guided sclerotherapy with foam and endovenous laser therapy.
Detailed Description
Inclusion criteria: Ultrasound confirmed GSV insufficiency (reflux time >0.5 second and vein diameter ≥0.5 cm) non-treated GSV varicosis CEAP -classification > C2 and As2 >18 years old Informed consent. Exclusion criteria: Acute venous thrombosis / phlebitis Absence of deep venous system Vascular syndromes Post-thrombotic syndrome of occlusive type Contra-indications for surgery use of anticoagulants Primary outcomes: 1. anatomical success using US (absence of GSV or flow) (at 3 months, 1 and 5 year) Secondary outcomes: treatment induced adverse events and complications (after 3 months) patient reported outcomes (HRQOL and treatment satisfaction)(after 3 months) cost effectiveness analyses (after 1 and 5 years) Included patients: total of 240 (80 per arm) Study start: May 2007 (recruitment ongoing) Study completion: May 2011 Follow up after 3 months, 1, 2, 3, 4 and 5 years Location: department of dermatology, Erasmus MC, Rotterdam, The Netherlands Principle investigators: M. Kockaert, T. Nijsten & M. Neumann Publications: Rasmussen LH, Bjoern L, Lawaetz M, Blemings A, Lawaetz B, Eklof B. Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins: short-term results. J Vasc Surg. 2007 Aug;46(2):308-15. Epub 2007 Jun 27. Sharif MA, Lau LL, Lee B, Hannon RJ, Soong CV. Role of endovenous laser treatment in the management of chronic venous insufficiency. Ann Vasc Surg. 2007 Sep;21(5):551-5. Mundy L, Merlin TL, Fitridge RA, Hiller JE. Systematic review of endovenous laser treatment for varicose veins. Br J Surg. 2005 Oct;92(10):1189-94. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C.Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007 Aug;94(8):925-36. Subramonia S, Lees TA.The treatment of varicose veins.Ann R Coll Surg Engl. 2007 Mar;89(2):96-100. Bohler K. Varicose veins: disfigurement or disease? Herz. 2007 Feb;32(1):18-25. Bamigboye AA, Smyth R. Interventions for varicose veins and leg oedema in pregnancy. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001066. van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T. New endovenous therapies of truncal varicosities are more effective than surgical stripping and sclerotherapy: meta-analysis and meta-regression. Lancet, Submitted

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Varicose Vein
Keywords
endovenous laser therapy, sclerotherapy, crossectomy and stripping, surgery, treatment, varicose veins

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
240 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Surgery: crossectomy plus short stripping
Arm Title
2
Arm Type
Active Comparator
Arm Description
ultrasound guided sclerotherapy with foam (3% polidocanol)
Arm Title
3
Arm Type
Active Comparator
Arm Description
Endovenous laser therapy (940 nm, about 70 J/cm)
Intervention Type
Procedure
Intervention Name(s)
crossectomy and short stripping
Intervention Description
under spinal or complete anaesthesia
Intervention Type
Procedure
Intervention Name(s)
ultrasound guided sclerotherapy with foam
Intervention Description
1 part 3% polidocanol mixed with 3 parts of air. Between 3cc - 12 cc per varicose vein>
Intervention Type
Procedure
Intervention Name(s)
endovenous laser therapy
Intervention Description
940 nm Diode laser. About 70 J/cm will be administered. Disposables from Angiocare (registered) will be used.
Primary Outcome Measure Information:
Title
anatomical success rate (absence or obliteration of GSV on US examination)
Time Frame
3 months, 1 and 5 years
Secondary Outcome Measure Information:
Title
treatment related adverse events and complications
Time Frame
3 months, 1 and 5 years
Title
patient reported outcomes (HRQOL and treatment satisfaction)
Time Frame
3 months, 1 and 5 years
Title
cost effectiveness analysis
Time Frame
3 months, 1 and 5 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: primary insufficient GSV confirmed by US: reflux>0.5 sec and diameter>0.5cm. non-treated insufficient GSV >18 years informed consent Exclusion Criteria: acute thrombosis or phlebitis absence of deep venous system vascular syndromes use of anticoagulants contraindications surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael Kockaert, MD
Phone
31 10 4634580
Email
M.KOCKAERT@ERASMUSMC.NL
First Name & Middle Initial & Last Name or Official Title & Degree
Tamar Nijsten, MD, PhD
Phone
31 10 4631019
Email
t.nijsten@erasmusmc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martino Neumann, MD, PhD
Organizational Affiliation
Erasmus Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Erasmus MC dermatology
City
Rotterdam
ZIP/Postal Code
3000 CA
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michael Kockaert, MD
Phone
31 10 4634580
Email
m.kockaert@erasmusmc.nl
First Name & Middle Initial & Last Name & Degree
Tamar Nijsten, MD, PhD
Phone
31 10 4631019
Email
t.nijsten@ersmusmc.nl
First Name & Middle Initial & Last Name & Degree
Prof. sambeek, MD, PhD

12. IPD Sharing Statement

Citations:
PubMed Identifier
26132315
Citation
van der Velden SK, Biemans AA, De Maeseneer MG, Kockaert MA, Cuypers PW, Hollestein LM, Neumann HA, Nijsten T, van den Bos RR. Five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br J Surg. 2015 Sep;102(10):1184-94. doi: 10.1002/bjs.9867. Epub 2015 Jul 1.
Results Reference
derived
PubMed Identifier
23769603
Citation
Biemans AA, Kockaert M, Akkersdijk GP, van den Bos RR, de Maeseneer MG, Cuypers P, Stijnen T, Neumann MH, Nijsten T. Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg. 2013 Sep;58(3):727-34.e1. doi: 10.1016/j.jvs.2012.12.074. Epub 2013 Jun 13.
Results Reference
derived

Learn more about this trial

Surgery or Noninvasive Therapy for Varicose Veins

We'll reach out to this number within 24 hrs